Resolute Financial, LLC E Ffector Therapeutics, Inc. Transaction History
Resolute Financial, LLC
- $118 Million
- Q4 2022
A detailed history of Resolute Financial, LLC transactions in E Ffector Therapeutics, Inc. stock. As of the latest transaction made, Resolute Financial, LLC holds 31,000 shares of EFTR stock, worth $4,030. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,000
Previous 31,000
-0.0%
Holding current value
$4,030
Previous $18,000
27.78%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding EFTR
# of Institutions
6Shares Held
6.53MCall Options Held
0Put Options Held
0-
Abingworth LLP London, X04.82MShares$626,8740.69% of portfolio
-
Oup Management Co., LLC1.03MShares$133,3401.38% of portfolio
-
Evolution Capital Management LLC Crystal Bay, NV528KShares$68,6251.04% of portfolio
-
Parallel Advisors, LLC67.7KShares$8,8050.03% of portfolio
-
Blackstone Inc New York, NY52.3KShares$6,8040.0% of portfolio
About eFFECTOR Therapeutics, Inc.
- Ticker EFTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,452,800
- Market Cap $5.39M
- Description
- eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...